Procalcitonin-guided antibiotic discontinuation in ventilator-associated pneumonia: a prospective observational study

References

• Davis KA. Ventilator-associated pneumonia: a review. J Intensive Care Med. 2006;21(4):211–226. doi:10.1177/088506660628883716855056
   PubMedGoogle Scholar
• Pugh R, Grant C, Cooke RP, Dempsey G. Short-course versus prolonged-course antibiotic therapy for hospital-acquired pneumonia in critically ill adults. Cochrane Database Syst Rev. 2015;(8):CD007577.26301604
   PubMed Web of Science ®Google Scholar
• Singh N, Rogers P, Atwood CW, Wagener MM, Yu VL. Short-course empiric antibiotic therapy for patients with pulmonary infiltrates in the intensive care unit. A proposed solution for indiscriminate antibiotic prescription. Am J Respir Crit Care Med. 2000;162(2 Pt 1):505–511. doi:10.1164/ajrccm.162.2.990909510934078
   PubMed Web of Science ®Google Scholar
• Povoa P, Martin-Loeches I, Ramirez P, et al. Biomarkers kinetics in the assessment of ventilator-associated pneumonia response Biomarkers kineticsto antibiotics – results from the BioVAP study. J Crit Care. 2017;41:91–97. doi:10.1016/j.jcrc.2017.05.00728502892
   PubMed Web of Science ®Google Scholar
• Povoa P, Coelho L, Almeida E, et al. C-reactive protein as a marker of ventilator-associated pneumonia resolution: a pilot study. Eur Respir J. 2005;25(5):804–812. doi:10.1183/09031936.05.0007170415863636
   PubMed Web of Science ®Google Scholar
• Kalil AC, Metersky ML, Klompas M, et al. Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the Infectious Diseases Society of America and the American Thoracic Society. Clin Infect Dis. 2016;63(5):e61–e111. doi:10.1093/cid/ciw35327418577
   PubMed Web of Science ®Google Scholar
• Torres A, Niederman MS, Chastre J, et al. International ERS/ESICM/ESCMID/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia: guidelines for the management of hospital-acquired pneumonia (HAP)/ventilator-associated pneumonia (VAP) of the European Respiratory Society (ERS), European Society of Intensive Care Medicine (ESICM), European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and Asociacion Latinoamericana del Torax (ALAT). Eur Respir J. 2017;50(3). doi:10.1183/13993003.00711-2017.
   Web of Science ®Google Scholar
• Luyt CE, Combes A, Trouillet JL, Chastre J. Value of the serum procalcitonin level to guide antimicrobial therapy for patients with ventilator-associated pneumonia. Semin Respir Crit Care Med. 2011;32(2):181–187. doi:10.1055/s-0031-127553021506054
   PubMed Web of Science ®Google Scholar
• Stolz D, Smyrnios N, Eggimann P, et al. Procalcitonin for reduced antibiotic exposure in ventilator-associated pneumonia: a randomised study. Eur Respir J. 2009;34(6):1364–1375. doi:10.1183/09031936.0005320919797133
   PubMed Web of Science ®Google Scholar
• American Thoracic S, Infectious Diseases Society of A. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med. 2005;171(4):388–416. doi:10.1164/rccm.200405-644ST15699079
   PubMed Web of Science ®Google Scholar
• Chastre J, Wolff M, Fagon JY, et al. Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults: a randomized trial. JAMA. 2003;290(19):2588–2598. doi:10.1001/jama.290.19.258814625336
   PubMed Web of Science ®Google Scholar
• Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. 22nd Informational Supplement CLSI M100-S22. CLSI; 2012; Wayne, PA, USA. doi:10.1094/PDIS-11-11-0999-PDN
   Google Scholar
• Fujitani S, Cohen-Melamed MH, Tuttle RP, Delgado E, Taira Y, Darby JM. Comparison of semi-quantitative endotracheal aspirates to quantitative non-bronchoscopic bronchoalveolar lavage in diagnosing ventilator-associated pneumonia. Respir Care. 2009;54(11):1453–1461.19863828
   PubMed Web of Science ®Google Scholar
• Luna CM, Blanzaco D, Niederman MS, et al. Resolution of ventilator-associated pneumonia: prospective evaluation of the clinical pulmonary infection score as an early clinical predictor of outcome. Crit Care Med. 2003;31(3):676–682. doi:10.1097/01.CCM.0000055380.86458.1E12626968
   PubMed Web of Science ®Google Scholar
• Pugh R, Grant C, Cooke RP, Dempsey G. Short-course versus prolonged-course antibiotic therapy for hospital-acquired pneumonia in critically ill adults. Cochrane Database Syst Rev. 2011;(10):CD007577.21975771
   PubMed Web of Science ®Google Scholar
• Pinzone MR, Cacopardo B, Abbo L, Nunnari G. Optimal duration of antimicrobial therapy in ventilator-associated pneumonia: what is the role for procalcitonin? J Glob Antimicrob Resist. 2014;2(4):239–244. doi:10.1016/j.jgar.2014.06.00427873682
   PubMed Web of Science ®Google Scholar
• Charles PE, Ladoire S, Aho S, et al. Serum procalcitonin elevation in critically ill patients at the onset of bacteremia caused by either Gram negative or Gram positive bacteria. BMC Infect Dis. 2008;8:38. doi:10.1186/1471-2334-8-3818366777
   PubMed Web of Science ®Google Scholar
• Petrikkos GL, Christofilopoulou SA, Tentolouris NK, Charvalos EA, Kosmidis CJ, Daikos GL. Value of measuring serum procalcitonin, C-reactive protein, and mannan antigens to distinguish fungal from bacterial infections. Eur J Clin Microbiol Infect Dis. 2005;24(4):272–275. doi:10.1007/s10096-005-1312-z15902534
   PubMed Web of Science ®Google Scholar
• Sugimoto K, Shimizu N, Matsumura N, et al. Procalcitonin as a useful marker to decide upon intervention for urinary tract infection. Infect Drug Resist. 2013;6:83–86. doi:10.2147/IDR.S4716123966797
   PubMedGoogle Scholar
• Schuetz P, Albrich W, Mueller B. Procalcitonin for diagnosis of infection and guide to antibiotic decisions: past, present and future. BMC Med. 2011;9:107. doi:10.1186/1741-7015-9-10721936959
   PubMed Web of Science ®Google Scholar
• Pfister R, Kochanek M, Leygeber T, et al. Procalcitonin for diagnosis of bacterial pneumonia in critically ill patients during 2009 H1N1 influenza pandemic: a prospective cohort study, systematic review and individual patient data meta-analysis. Crit Care. 2014;18(2):R44. doi:10.1186/cc1371224612487
   PubMed Web of Science ®Google Scholar
• Wongsurakiat P, Tulatamakit S. Clinical pulmonary infection score and a spot serum procalcitonin level to guide discontinuation of antibiotics in ventilator-associated pneumonia: a study in a single institution with high prevalence of nonfermentative gram-negative bacilli infection. Ther Adv Respir Dis. 2018;12:1753466618760134. doi:10.1177/175346661876013429506460
   PubMed Web of Science ®Google Scholar
• Schuetz P, Christ-Crain M, Thomann R, et al. Effect of procalcitonin-based guidelines vs standard guidelines on antibiotic use in lower respiratory tract infections: the ProHOSP randomized controlled trial. JAMA. 2009;302(10):1059–1066. doi:10.1001/jama.2009.129719738090
   PubMed Web of Science ®Google Scholar
• Zhang T, Wang Y, Yang Q, Dong Y. Procalcitonin-guided antibiotic therapy in critically ill adults: a meta-analysis. BMC Infect Dis. 2017;17(1):514. doi:10.1186/s12879-017-2757-228738787
   PubMed Web of Science ®Google Scholar
• Bouadma L, Luyt CE, Tubach F, et al. Use of procalcitonin to reduce patients’ exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial. Lancet. 2010;375(9713):463–474. doi:10.1016/S0140-6736(09)61879-120097417
   PubMed Web of Science ®Google Scholar
• Schuetz P, Chiappa V, Briel M, Greenwald JL. Procalcitonin algorithms for antibiotic therapy decisions: a systematic review of randomized controlled trials and recommendations for clinical algorithms. Arch Intern Med. 2011;171(15):1322–1331. doi:10.1001/archinternmed.2011.31821824946
   PubMed Web of Science ®Google Scholar
• Giantsou E, Liratzopoulos N, Efraimidou E, et al. De-escalation therapy rates are significantly higher by bronchoalveolar lavage than by tracheal aspirate. Intensive Care Med. 2007;33(9):1533–1540. doi:10.1007/s00134-007-0619-x17549458
   PubMed Web of Science ®Google Scholar
• Huang H, Chen B, Liu G, et al. A multi-center study on the risk factors of infection caused by multi-drug resistant Acinetobacter baumannii. BMC Infect Dis. 2018;18(1):11. doi:10.1186/s12879-018-3109-629304746
   PubMed Web of Science ®Google Scholar
• Masse J, Elkalioubie A, Blazejewski C, et al. Colonization pressure as a risk factor of ICU-acquired multidrug resistant bacteria: a prospective observational study. Eur J Clin Microbiol Infect Dis. 2017;36(5):797–805. doi:10.1007/s10096-016-2863-x28000030
   PubMed Web of Science ®Google Scholar
• Seguin P, Fedun Y, Laviolle B, Nesseler N, Donnio PY, Malledant Y. Risk factors for multidrug-resistant bacteria in patients with post-operative peritonitis requiring intensive care. J Antimicrob Chemother. 2010;65(2):342–346. doi:10.1093/jac/dkp43920008043
   PubMed Web of Science ®Google Scholar
• Dent LL, Marshall DR, Pratap S, Hulette RB. Multidrug resistant Acinetobacter baumannii: a descriptive study in a city hospital. BMC Infect Dis. 2010;10:196. doi:10.1186/1471-2334-10-19620609238
   PubMed Web of Science ®Google Scholar
• Falagas ME, Rafailidis PI. Attributable mortality of Acinetobacter baumannii: no longer a controversial issue. Crit Care. 2007;11(3):134. doi:10.1186/cc591117543135
   PubMed Web of Science ®Google Scholar
• Hirsch EB, Tam VH. Impact of multidrug-resistant Pseudomonas aeruginosa infection on patient outcomes. Expert Rev Pharmacoecon Outcomes Res. 2010;10(4):441–451. doi:10.1586/erp.10.4920715920
   PubMed Web of Science ®Google Scholar
• Tam VH, Rogers CA, Chang KT, Weston JS, Caeiro JP, Garey KW. Impact of multidrug-resistant Pseudomonas aeruginosa bacteremia on patient outcomes. Antimicrob Agents Chemother. 2010;54(9):3717–3722. doi:10.1128/AAC.00207-1020585122
   PubMed Web of Science ®Google Scholar
• Zilberberg MD, Nathanson BH, Sulham K, Fan W, ShorrAF. Multidrug resistance, inappropriate empiric therapy, and hospital mortality in Acinetobacter baumannii pneumonia and sepsis. Crit Care. 2016;20(1):221. doi:10.1186/s13054-016-1362-x27417949
   PubMed Web of Science ®Google Scholar